NCT00113997View on ClinicalTrials.gov

Safety and Dosing Evaluation of REG1 Anticoagulation System

PHASE1CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

October 31, 2005

Conditions
Healthy
Interventions
DRUG

REG1

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00113997 - Safety and Dosing Evaluation of REG1 Anticoagulation System | Biotech Hunter | Biotech Hunter